bioRxivCell BiologyPreprint
Polyalanine disease mutations impair UBA6-dependent ubiquitination
F. Amer-Sarsour, D. Falik, Y. Berdichevsky, A. Kordonsky, G. Prag, G. Vatine, A. Ashkenazi
Abstract
Expansion mutations in polyalanine stretches are now associated with a growing number of human diseases with common genotypes and similar phenotypes 1-6. These similarities prompted us to query the normal function of physiological polyalanine stretches, and investigate whether a common molecular mechanism is involved in these diseases. Here, we show that UBA6, an E1 ubiquitin-activating enzyme 7, 8, recognizes a polyalanine stretch within its cognate E2 ubiquitin-conjugating enzyme, USE1. Aberrations in this polyalanine stretch reduced ubiquitin transfer to USE1 and downstream target, the E3 ubiquitin ligase, E6AP. Intriguingly, we identified competition for the UBA6-USE1 interaction by various proteins with polyalanine expansion mutations in the disease state. In mouse primary neurons, the deleterious interactions of expanded polyalanine proteins with UBA6, alter the levels and ubiquitination-dependent degradation of E6AP, which in turn affected the levels of the synaptic protein, Arc. These effects could be observed in induced pluripotent stem cell-derived autonomic neurons from patients with polyalanine expansion mutations. Our results suggest a shared mechanism for such mutations, which may contribute to the congenital malformations seen in polyalanine diseases.
- organism: mouse
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: cell signaling & trafficking
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function
Rossella Avagliano Trezza, A. Mattijs Punt, … Ben Distel·Scientific ReportsPeer-reviewed·Feb 4, 2021
- Aberrant accumulation of α-synuclein might be linked with the progressive motor deficits in a mouse model of Angelman syndrome
Sagarika Das, Bhaskarjyoti Giri, Nihar Ranjan Jana·bioRxiv·Sep 3, 2026
- TRAPPC8 Is an Endogenous Brake on UFMylation That Suppresses Tauopathy
Yuansong Wan, Ethan Cordes, … Li Gan·bioRxiv·Aug 23, 2026
- SUBCELLULAR FUNCTIONS OF UBE3A ISOFORMS DRIVE SYNAPTIC DYSFUNCTION IN ANGELMAN SYNDROME
Martina Biagioni, Federica Baronchelli, … Matteo Fossati·bioRxiv·Mar 26, 2026
- Shared and Distinct Mechanisms of UBA1 Inactivation Across Different Diseases
J. C. Collins, S. J. Magaziner, … A. Werner·bioRxiv·Oct 10, 2023
- Deleting a UBE3A substrate rescues impaired hippocampal physiology and learning in Angelman syndrome mice
Gabrielle L. Sell, Wendy Xin, … Seth S. Margolis·Scientific ReportsPeer-reviewed·Sep 30, 2021